What is the long-term trend for Tandem Diabetes Care's deferred revenue, net of current portion?

Over 4 years (2021 to 2025), Tandem Diabetes Care's deferred revenue, net of current portion has grown at a -15.9% compound annual growth rate (CAGR), from $16.94M to $8.47M.

Tandem Diabetes Care TNDM Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

InsuletPODD

——

MannkindMNKD

——

OmnicellOMCL

——

Teladoc HealthTDOC

——

Butterfly NetworkBFLY

——

Tempus AI, Inc.TEM

——

Other financials

Income statement

See full

Revenue$247.2M+5.5%

Gross profit$136.8M+15.5%

Operating income-$17.4M+85.6%

Net income-$20.4M+84.4%

EPS (diluted)-$0.30+84.8%

Balance sheet

See full

Cash & equivalents$179.3M+235%

Total debt$734.7M+49.0%

Total equity$132.4M-14.7%

Total assets$1.2B+25.1%

Cash flow

See full

Operating cash flow$11.1M+160%

CapEx$6.3M+111%

Free cash flow$4.8M+123%

Valuation

See full

Market cap$1.03B-23.6%

Enterprise value$1.58B-11.3%

P/S1×-0.4×

Profitability

See full

Gross margin54.9%+2.7pp

Operating margin-8.2%-2.9pp

Net margin-9.2%-3.1pp

FCF margin-0.8%-0.4pp

Returns & leverage

See full

Return on equity-65.7%-14.7pp

Debt / equity5.5×+2.4×

Current ratio3.6×+1.3×

Where this comes from

Reported directly by Tandem Diabetes Care in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tandem Diabetes Care's deferred revenue, net of current portion?: Tandem Diabetes Care (TNDM) reported deferred revenue, net of current portion of $7.99M in Q1 2026.
How has Tandem Diabetes Care's deferred revenue, net of current portion changed year-over-year?: Tandem Diabetes Care's deferred revenue, net of current portion decreased by 18.9% year-over-year, from $9.86M to $7.99M.
What is the long-term trend for Tandem Diabetes Care's deferred revenue, net of current portion?: Over 4 years (2021 to 2025), Tandem Diabetes Care's deferred revenue, net of current portion has grown at a -15.9% compound annual growth rate (CAGR), from $16.94M to $8.47M.